SBIO
Fund Stats as of 09/25/2017
Symbol SBIO
CUSIP 00162Q 593
ISIN US00162Q5936
Inception Date 12/30/2014
Dividends Paid Annual
Fund Type Exchange Traded Fund
Market Price $30.84
Last Trade Price $30.85
NAV $30.85
NAV Change $0.13
Total Net Assets $129,567,486
Total Market Value $129,591,840
Premium/Discount(%) -0.03%
Difference ($) $-0.01
Volume 18,254
Shares Outstanding 4,200,000
Expenses as of 03/31/2016
Management Fee0.50%
Other Expenses0.00%
Total Operating Expenses0.50%
Fund Resources
Summary Prospectus 
Statement of Additional Information 
Quarterly Fact Sheet 
Quarterly Scorecard 
Statutory Prospectus 
Resource Library  

Daily Fund Holdings 93 total, as of 09/25/2017, subject to change

SecuritySymbolWeight
Bluebird Bio Inc.BLUE4.52%
Exelixis Inc.EXEL4.10%
Galapagos NVGLPG3.82%
ACADIA Pharmaceuticals Inc.ACAD3.50%
Taro Pharmaceutical Industries Ltd.TARO3.42%
Akorn Inc.AKRX3.14%
FibroGen Inc.FGEN3.12%
OPKO Health Inc.OPK2.92%
BeiGene Ltd.BGNE2.75%
Nektar TherapeuticsNKTR2.72%
Agios Pharmaceuticals Inc.AGIO2.44%
Spark Therapeutics Inc.ONCE2.37%
Portola Pharmaceuticals Inc.PTLA2.36%
Ligand Pharmaceuticals Inc.LGND2.16%
GW Pharmaceuticals PLCGWPH2.09%
Axovant Sciences Ltd.AXON1.98%
Loxo Oncology Inc.LOXO1.94%
Advanced Accelerator Applications SAAAAP1.87%
Halozyme Therapeutics Inc.HALO1.82%
Sage Therapeutics Inc.SAGE1.80%
Ultragenyx Pharmaceutical Inc.RARE1.71%
Ironwood Pharmaceuticals Inc.IRWD1.66%
DBV Technologies SADBVT1.58%
Supernus Pharmaceuticals Inc.SUPN1.51%
Horizon Pharma PLCHZNP1.51%
Array BioPharma Inc.ARRY1.48%
Endo International PLCENDP1.45%
Aerie Pharmaceuticals Inc.AERI1.45%
Theravance Biopharma Inc.TBPH1.38%
Impax Laboratories Inc.IPXL1.29%
Emergent BioSolutions Inc.EBS1.21%
Intercept Pharmaceuticals Inc.ICPT1.17%
Pacira Pharmaceuticals Inc.PCRX1.15%
MyoKardia Inc.MYOK1.14%
Biohaven Pharmaceutical Holding Co. Ltd.BHVN1.03%
Acceleron Pharma Inc.XLRN1.02%
Aimmune Therapeutics Inc.AIMT0.96%
Global Blood Therapeutics Inc.GBT0.94%
Ascendis Pharma ASASND0.89%
Acorda Therapeutics Inc.ACOR0.85%
Neuroderm Ltd.NDRM0.78%
Five Prime Therapeutics Inc.FPRX0.78%
Epizyme Inc.EPZM0.73%
Akebia Therapeutics Inc.AKBA0.64%
Enanta Pharmaceuticals Inc.ENTA0.63%
Aduro Biotech Inc.ADRO0.62%
PTC Therapeutics Inc.PTCT0.61%
Flexion Therapeutics Inc.FLXN0.61%
Adaptimmune Therapeutics PLCADAP0.61%
Revance Therapeutics Inc.RVNC0.59%
Aclaris Therapeutics Inc.ACRS0.59%
G1 Therapeutics Inc.GTHX0.54%
AnaptysBio Inc.ANAB0.53%
Paratek Pharmaceuticals Inc.PRTK0.52%
Seres Therapeutics Inc.MCRB0.52%
Achaogen Inc.AKAO0.51%
AMAG Pharmaceuticals Inc.AMAG0.49%
MacroGenics Inc.MGNX0.48%
Lannett Co. Inc.LCI0.48%
Reata Pharmaceuticals Inc.RETA0.45%
Achillion Pharmaceuticals Inc.ACHN0.44%
SciClone Pharmaceuticals Inc.SCLN0.44%
Sucampo Pharmaceuticals Inc.SCMP0.42%
PDL BioPharma Inc.PDLI0.39%
Aurinia Pharmaceuticals IncAUPH0.39%
Progenics Pharmaceuticals Inc.PGNX0.38%
Atara Biotherapeutics Inc.ATRA0.37%
Adamas Pharmaceuticals Inc.ADMS0.36%
Jounce Therapeutics Inc.JNCE0.36%
NantKwest Inc.NK0.33%
BioCryst Pharmaceuticals Inc.BCRX0.32%
Depomed Inc.DEPO0.29%
Avadel Pharmaceuticals PLCAVDL0.29%
UroGen Pharma Ltd.URGN0.28%
Corbus Pharmaceuticals Holdings Inc.CRBP0.26%
Idera Pharmaceuticals Inc.IDRA0.26%
Aquinox Pharmaceuticals Inc.AQXP0.25%
Ra Pharmaceuticals Inc.RARX0.25%
Concert Pharmaceuticals Inc.CNCE0.24%
Minerva Neurosciences Inc.NERV0.22%
Forward Pharma ASFWP0.20%
Syndax PharmaceuticSNDX0.19%
Chimerix Inc.CMRX0.18%
Tocagen Inc.TOCA0.18%
Ovid therapeutics Inc.OVID0.16%
Ocular Therapeutix Inc.OCUL0.14%
Matinas BioPharma Holdings Inc.MTNB0.09%
Otonomy Inc.OTIC0.08%
Versartis Inc.VSAR0.07%
Zynerba Pharmaceuticals Inc.ZYNE0.06%
Dyax Corp. - CVRDYAX-CVR0.00%
State Street Institutional Treasury Plus Money Market FundTPIXX0.18%
Cash and Equivalents0.00%
Total Net Assets 100.00%
Security
Bluebird Bio Inc.
Exelixis Inc.
Galapagos NV
ACADIA Pharmaceuticals Inc.
Taro Pharmaceutical Industries Ltd.
Akorn Inc.
FibroGen Inc.
OPKO Health Inc.
BeiGene Ltd.
Nektar Therapeutics
Agios Pharmaceuticals Inc.
Spark Therapeutics Inc.
Portola Pharmaceuticals Inc.
Ligand Pharmaceuticals Inc.
GW Pharmaceuticals PLC
Axovant Sciences Ltd.
Loxo Oncology Inc.
Advanced Accelerator Applications SA
Halozyme Therapeutics Inc.
Sage Therapeutics Inc.
Ultragenyx Pharmaceutical Inc.
Ironwood Pharmaceuticals Inc.
DBV Technologies SA
Supernus Pharmaceuticals Inc.
Horizon Pharma PLC
Array BioPharma Inc.
Endo International PLC
Aerie Pharmaceuticals Inc.
Theravance Biopharma Inc.
Impax Laboratories Inc.
Emergent BioSolutions Inc.
Intercept Pharmaceuticals Inc.
Pacira Pharmaceuticals Inc.
MyoKardia Inc.
Biohaven Pharmaceutical Holding Co. Ltd.
Acceleron Pharma Inc.
Aimmune Therapeutics Inc.
Global Blood Therapeutics Inc.
Ascendis Pharma AS
Acorda Therapeutics Inc.
Neuroderm Ltd.
Five Prime Therapeutics Inc.
Epizyme Inc.
Akebia Therapeutics Inc.
Enanta Pharmaceuticals Inc.
Aduro Biotech Inc.
PTC Therapeutics Inc.
Flexion Therapeutics Inc.
Adaptimmune Therapeutics PLC
Revance Therapeutics Inc.
Aclaris Therapeutics Inc.
G1 Therapeutics Inc.
AnaptysBio Inc.
Paratek Pharmaceuticals Inc.
Seres Therapeutics Inc.
Achaogen Inc.
AMAG Pharmaceuticals Inc.
MacroGenics Inc.
Lannett Co. Inc.
Reata Pharmaceuticals Inc.
Achillion Pharmaceuticals Inc.
SciClone Pharmaceuticals Inc.
Sucampo Pharmaceuticals Inc.
PDL BioPharma Inc.
Aurinia Pharmaceuticals Inc
Progenics Pharmaceuticals Inc.
Atara Biotherapeutics Inc.
Adamas Pharmaceuticals Inc.
Jounce Therapeutics Inc.
NantKwest Inc.
BioCryst Pharmaceuticals Inc.
Depomed Inc.
Avadel Pharmaceuticals PLC
UroGen Pharma Ltd.
Corbus Pharmaceuticals Holdings Inc.
Idera Pharmaceuticals Inc.
Aquinox Pharmaceuticals Inc.
Ra Pharmaceuticals Inc.
Concert Pharmaceuticals Inc.
Minerva Neurosciences Inc.
Forward Pharma AS
Syndax Pharmaceutic
Chimerix Inc.
Tocagen Inc.
Ovid therapeutics Inc.
Ocular Therapeutix Inc.
Matinas BioPharma Holdings Inc.
Otonomy Inc.
Versartis Inc.
Zynerba Pharmaceuticals Inc.
Dyax Corp. - CVR
State Street Institutional Treasury Plus Money Market Fund
Cash and Equivalents
Total Net Assets